Table 1.
Source | Study Design | Sample of Participants (No. of Women) |
Sample Type | Exposure | Main Findings |
---|---|---|---|---|---|
Akgül et al. (2019), Turkey [84] |
Case-control study | 95 aged 12–18 years: 62 with PCOS, 33 controls | Blood plasma, urine samples | BPA, phthalates |
|
Akin et al. (2015), Turkey [85] |
Cross-sectional study | 173 aged 13–19 years: 112 with PCOS, 61 controls | Blood serum | BPA |
|
Gu et al. (2019) [86] | Case-control study | 123: 40 with PCOS, 83 controls | Urine sample | Organic UV filters, BPA, triclosan |
|
Hossein Rashidi et al. (2017), Iran [87] |
Case-control study | 102: 51 with PCOS, 51 controls | First morning urine sample | BPA |
|
Jędrzejuk et al. (2019), Poland [88] |
Pilot study | 63: 27 with PCOS, 36 controls | Blood sample | BPA |
|
Kandaraki et al. (2011), United Kingdom, Greece [89] |
Cross-sectional study | 171: 71 with PCOS, 100 controls | Blood serum | BPA |
|
Konieczna et al. (2018), Poland [90] |
Cross-sectional study | 186: 106 with PCOS, 80 controls | Blood serum | BPA |
|
Lazúrová et al. (2021), Slovakia [91] |
Case-control study | 118: 86 with PCOS, 32 controls | Fasting blood and morning urinary samples | BPA |
|
Luo et al. (2020), China [92] |
Case-control study | 357: 119 with PCOS, 238 controls | Blood plasma | BPA, polybrominated diphenyl ethers, phthalates |
|
Šimková et al. (2020), Czech Republic [93] |
Case-control study | 39: 19 with PCOS (9 normal-weight, 10 obese), 20 controls | Blood plasma | Parabens, BPA, BPS, BPF, BPAF |
|
Tarantino et al. (2013), Italy [94] |
Cross-sectional study | 60: 40 with PCOS, 20 controls | Blood serum | BPA |
|
Vagi et al. (2014), USA [95] |
Case-control study | 102: 52 with PCOS, 50 controls | Blood and urinary samples | Brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and BPA |
|
Vahedi et al. (2016), Iran [96] |
Case-control study | 124: 62 with PCOS, 62 controls | Blood serum | BPA |
|
Wang et al. (2017), China [97] |
Case-control study | 38: 21 with PCOS, 17 controls | Follicular fluid and ovarian granulosa cells | BPA |
|
Zhou et al. (2016), China [98] |
Cross-sectional study | 268 infertile women diagnosed with PCOS | Urinary sample | BPA |
|
Abbreviations: A, androstenedione; AFC, antral follicle count; AMH, anti-Müllerian hormone; BPA, bisphenol A; BPAF, bispheol AF; BPF, bispheol F; BPS, bispheol S; CRP, C-reactive protein; DHEAS, dehydroepiandrosterone sulfate; FAI, free androgen index; FSH, follicle–stimulating hormone; HOMA IR, Homeostatic Model Assessment for Insulin Resistance; IL-6, interleukin 6; LH, luteinizing hormone; PCOS, polycystic ovary syndrome; PDGF-bb, platelet derived growth factor bb; SHBG, sex hormone binding globulin; UGT, uridine diphosphate-glucuronosyl transferase; VDBP, Vitamin D–binding protein; VEGF, vascular endothelial growth factor; T, testosterone; TCS, triclosan; TSH, thyroid–stimulating hormone.